Cite

HARVARD Citation

    Yale, J. et al. (n.d.). Efficacy and safety of canagliflozin in subjects with type 2 diabetes and chronic kidney disease. Diabetes, obesity & metabolism. 15 (5), pp. 463-473. [Online]. 
  
Back to record